Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Suvannasankha A, Bahlis N, Trudel S, Weisel K, Koenecke C, Oriol A, Voorhees PM, Alonso AA, Callander NS, Mateos MV, Reddy N, Hakim S, LaMacchia J, Patel N, Williams D, Jewell RC, Zhou X, Gupta I, Opalinska J, Nooka AK.
Suvannasankha A, et al. Among authors: alonso aa.
Cancer. 2024 Apr 17. doi: 10.1002/cncr.35319. Online ahead of print.
Cancer. 2024.
PMID: 38630908